 Christine McMahon
Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 26 | 2026 | 686 | 4.300 |
Why?
| | fms-Like Tyrosine Kinase 3 | 5 | 2026 | 51 | 1.380 |
Why?
| | Aniline Compounds | 3 | 2019 | 122 | 1.250 |
Why?
| | Pyrazines | 3 | 2019 | 93 | 1.250 |
Why?
| | Myelodysplastic Syndromes | 3 | 2025 | 148 | 1.150 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 11 | 2026 | 280 | 1.050 |
Why?
| | Sulfonamides | 11 | 2026 | 581 | 0.930 |
Why?
| | Hematopoietic Stem Cell Transplantation | 6 | 2025 | 700 | 0.830 |
Why?
| | Azacitidine | 6 | 2026 | 157 | 0.750 |
Why?
| | Antineoplastic Agents | 4 | 2026 | 2207 | 0.730 |
Why?
| | Transplantation Conditioning | 2 | 2024 | 191 | 0.700 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 12 | 2026 | 1965 | 0.600 |
Why?
| | Clonal Evolution | 1 | 2019 | 47 | 0.570 |
Why?
| | Mutation | 10 | 2026 | 4093 | 0.560 |
Why?
| | Protein Kinase Inhibitors | 3 | 2019 | 980 | 0.550 |
Why?
| | ras Proteins | 1 | 2019 | 151 | 0.550 |
Why?
| | Molecular Targeted Therapy | 2 | 2024 | 439 | 0.490 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 881 | 0.490 |
Why?
| | Immunotherapy | 1 | 2018 | 667 | 0.390 |
Why?
| | Signal Transduction | 4 | 2026 | 5202 | 0.350 |
Why?
| | Nuclear Proteins | 3 | 2026 | 743 | 0.350 |
Why?
| | Proto-Oncogene Proteins | 2 | 2025 | 620 | 0.340 |
Why?
| | Prognosis | 6 | 2026 | 4323 | 0.320 |
Why?
| | Recurrence | 4 | 2025 | 1142 | 0.310 |
Why?
| | Voltage-Dependent Anion Channel 1 | 1 | 2025 | 15 | 0.230 |
Why?
| | STAT3 Transcription Factor | 2 | 2025 | 205 | 0.230 |
Why?
| | Activin Receptors, Type II | 1 | 2025 | 12 | 0.220 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2025 | 41 | 0.220 |
Why?
| | Drug Approval | 1 | 2025 | 93 | 0.210 |
Why?
| | Transplantation, Haploidentical | 1 | 2024 | 23 | 0.210 |
Why?
| | Oligonucleotides | 1 | 2025 | 153 | 0.210 |
Why?
| | Humans | 29 | 2026 | 145491 | 0.210 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 72 | 0.200 |
Why?
| | Aged, 80 and over | 7 | 2026 | 8326 | 0.200 |
Why?
| | Leukocytosis | 2 | 2020 | 32 | 0.200 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2024 | 103 | 0.190 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2024 | 141 | 0.180 |
Why?
| | Recombinant Fusion Proteins | 1 | 2025 | 667 | 0.180 |
Why?
| | Aged | 12 | 2026 | 26125 | 0.170 |
Why?
| | Middle Aged | 13 | 2026 | 36176 | 0.160 |
Why?
| | Survival | 1 | 2019 | 38 | 0.150 |
Why?
| | Disease Management | 2 | 2024 | 654 | 0.140 |
Why?
| | Retreatment | 1 | 2018 | 79 | 0.140 |
Why?
| | Treatment Outcome | 6 | 2026 | 11831 | 0.140 |
Why?
| | Mitochondria | 1 | 2025 | 990 | 0.140 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 271 | 0.140 |
Why?
| | Sweet Syndrome | 1 | 2017 | 10 | 0.130 |
Why?
| | Risk Factors | 2 | 2025 | 10874 | 0.130 |
Why?
| | Adult | 11 | 2025 | 40707 | 0.130 |
Why?
| | Young Adult | 6 | 2025 | 14192 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2017 | 185 | 0.120 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 359 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 553 | 0.110 |
Why?
| | Male | 13 | 2026 | 72817 | 0.110 |
Why?
| | Spiro Compounds | 2 | 2025 | 17 | 0.110 |
Why?
| | Muscle Proteins | 1 | 2017 | 242 | 0.110 |
Why?
| | Female | 13 | 2026 | 78763 | 0.110 |
Why?
| | Tumor Suppressor Proteins | 1 | 2017 | 320 | 0.110 |
Why?
| | Benzamides | 2 | 2025 | 224 | 0.100 |
Why?
| | Induction Chemotherapy | 2 | 2024 | 87 | 0.090 |
Why?
| | Remission Induction | 2 | 2026 | 309 | 0.090 |
Why?
| | Retrospective Studies | 7 | 2025 | 17269 | 0.090 |
Why?
| | Leukocyte Count | 2 | 2024 | 316 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1321 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2019 | 2045 | 0.080 |
Why?
| | Neoplastic Stem Cells | 2 | 2025 | 409 | 0.080 |
Why?
| | Leukapheresis | 2 | 2020 | 27 | 0.080 |
Why?
| | Daunorubicin | 1 | 2025 | 25 | 0.060 |
Why?
| | Cytarabine | 1 | 2025 | 66 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2025 | 3537 | 0.050 |
Why?
| | Splicing Factor U2AF | 1 | 2023 | 18 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2023 | 89 | 0.050 |
Why?
| | Gene Rearrangement | 1 | 2024 | 156 | 0.050 |
Why?
| | Chemotaxis | 1 | 2023 | 123 | 0.050 |
Why?
| | Neoplasm, Residual | 1 | 2023 | 143 | 0.050 |
Why?
| | Cell Survival | 1 | 2025 | 1094 | 0.040 |
Why?
| | Neoplasms | 1 | 2017 | 2897 | 0.040 |
Why?
| | Stem Cell Transplantation | 1 | 2023 | 190 | 0.040 |
Why?
| | Graft vs Host Disease | 1 | 2024 | 281 | 0.040 |
Why?
| | RNA Splicing | 1 | 2023 | 286 | 0.040 |
Why?
| | Adolescent | 3 | 2025 | 22485 | 0.040 |
Why?
| | Phosphorylation | 1 | 2025 | 1707 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 153 | 0.040 |
Why?
| | Mice | 3 | 2025 | 18338 | 0.040 |
Why?
| | Calcium | 1 | 2025 | 1190 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2023 | 2189 | 0.030 |
Why?
| | Dapsone | 1 | 2017 | 8 | 0.030 |
Why?
| | Hematologic Agents | 1 | 2017 | 3 | 0.030 |
Why?
| | Potassium Iodide | 1 | 2017 | 4 | 0.030 |
Why?
| | Filgrastim | 1 | 2017 | 13 | 0.030 |
Why?
| | Colchicine | 1 | 2017 | 21 | 0.030 |
Why?
| | Folic Acid Antagonists | 1 | 2017 | 8 | 0.030 |
Why?
| | Tubulin Modulators | 1 | 2017 | 11 | 0.030 |
Why?
| | Leukopenia | 1 | 2017 | 33 | 0.030 |
Why?
| | Neutrophils | 1 | 2023 | 1124 | 0.030 |
Why?
| | Hematopoiesis, Extramedullary | 1 | 2017 | 5 | 0.030 |
Why?
| | Primary Myelofibrosis | 1 | 2017 | 8 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1082 | 0.030 |
Why?
| | Arthralgia | 1 | 2017 | 61 | 0.030 |
Why?
| | Phenotype | 1 | 2025 | 3157 | 0.030 |
Why?
| | Janus Kinases | 1 | 2017 | 21 | 0.030 |
Why?
| | Machine Learning | 1 | 2022 | 590 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 195 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1544 | 0.030 |
Why?
| | Anemia | 1 | 2017 | 190 | 0.030 |
Why?
| | Thrombocytopenia | 1 | 2017 | 203 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2862 | 0.030 |
Why?
| | Animals | 3 | 2025 | 38141 | 0.030 |
Why?
| | Risk Assessment | 1 | 2024 | 3759 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2130 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2017 | 551 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2017 | 482 | 0.030 |
Why?
| | Inflammation | 1 | 2017 | 2883 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 5989 | 0.010 |
Why?
| | Child | 1 | 2024 | 22680 | 0.010 |
Why?
|
|
McMahon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|